Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spondyloarthritis, Axial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05527444
What this trial is testing

The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients

Who this might be right for
Ankylosing Spondylitis
Qilu Hospital of Shandong University 100
Not applicableStudy completedNCT00195416
What this trial is testing

Study Investigating Enbrel Treatment for Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Wyeth is now a wholly owned subsidiary of Pfizer 526
Testing effectiveness (Phase 2)Ended earlyNCT01118728
What this trial is testing

Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Sanofi 223
Post-approval studies (Phase 4)UnknownNCT05164198
What this trial is testing

REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)

Who this might be right for
Ankylosing SpondylitisAxial Spondyloarthritis
Hanyang University Seoul Hospital 448
Not applicableStudy completedNCT00751387
What this trial is testing

Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia

Who this might be right for
Ankylosing SpondylitisPsoriatic ArthritisRheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer 559
Large-scale testing (Phase 3)Study completedNCT03270501
What this trial is testing

Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation

Who this might be right for
Axial Spondyloarthritis
University Ghent 64
Post-approval studies (Phase 4)Ended earlyNCT03473665
What this trial is testing

Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis

Who this might be right for
Ankylosing SpondylitisAxial Spondyloarthritis
Columbia University 9
Not applicableStudy completedNCT05987111
What this trial is testing

Pilates in Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Pamukkale University 20
Large-scale testing (Phase 3)Study completedNCT00195819
What this trial is testing

Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Abbott 82
Not applicableStudy completedNCT04507763
What this trial is testing

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Pfizer 763
Not applicableLooking for participantsNCT07141017
What this trial is testing

Initial Standardized Global Review in Axial Spondyloarthritis

Who this might be right for
Axial Spondylarthritis (axSpA)
Association de Recherche Clinique en Rhumatologie 154
Post-approval studies (Phase 4)UnknownNCT02638896
What this trial is testing

Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Zhixiang Huang 100
Post-approval studies (Phase 4)Study completedNCT00444340
What this trial is testing

An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Wyeth is now a wholly owned subsidiary of Pfizer 70
Not applicableLooking for participantsNCT04751396
What this trial is testing

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Who this might be right for
Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more
M.D. Anderson Cancer Center 125
Post-approval studies (Phase 4)WithdrawnNCT00972218
What this trial is testing

Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease

Who this might be right for
SpondyloarthritisCrohn's Disease
University of Alberta
Not applicableStudy completedNCT04746196
What this trial is testing

Galectin-3 Level in Ankylosing Spondylitis Patients

Who this might be right for
Ankylosing Spondylitis
Recep Tayyip Erdogan University Training and Research Hospital 80
Not applicableNot Yet RecruitingNCT07810569
What this trial is testing

Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients

Who this might be right for
Meibomian Gland DysfunctionDry Eye SyndromesRheumatoid Arthritis+4 more
Assiut University 150
Not applicableStudy completedNCT03131661
What this trial is testing

A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs

Who this might be right for
Spondyloarthritis, Axial and Peripheral
Janssen-Cilag S.p.A. 351
Early research (Phase 1)Not Yet RecruitingNCT05962762
What this trial is testing

Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Asia Cell Therapeutics (Shanghai) Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT02159053
What this trial is testing

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

Who this might be right for
Spondylitis, Ankylosing
Novartis Pharmaceuticals 350
Next Page